May 25th, 2016|
The FDA has released a safety announcement alerting the public to a new study which found an increase in leg and foot amputations in patients who used Invokana (canagliflozin) to treat type 2 diabetes. This warning comes on the heels of several other FDA warnings regarding the drug such as diabetic ketoacidosis, kidney failure, and bone fractures.
Invokana is a prescription medicine which is used to help lower blood sugar in adults with type 2 diabetes. It is part of a class of drugs known as SGLT2 inhibitors which lower blood sugar by aiding the kidneys in removing sugar through urine. This new class of diabetes treatments has already been linked to many reports of kidney failure and there are already many claims which may be presented against the drug’s manufacturer, Johnson & Johnson.
In the ongoing Invokana study, an increased risk of leg and foot amputations have been found as amputations occurred about twice as often in patients who used Invokana as compared to patients who used a placebo. These amputations were most commonly around the toes and feet, but some patients had to have larger amputations of the leg after taking the drug.
If you or a loved one has fallen victim to these bad drugs and has suffered amputation, kidney failure, or has been hospitalized, our attorneys can help to make sure that you receive the compensation that you deserve. Cory Watson Attorneys believes companies that produce dangerous drugs should be held accountable for their negligence. If you were affected by any of the SGLT2 diabetes drugs, contact us today for a free, no obligation consultation.